The Role of DPP-IV Inhibitors in the Management of Type 2 Diabetes
An Overview
2008
Focus Medica Pte Ltd (Hersteller)
978-981-4206-17-4 (ISBN)
Focus Medica Pte Ltd (Hersteller)
978-981-4206-17-4 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
An interactive multimedia presentation with 3D & 2D animations, still images, illustrations with corresponding text and audio providing a unique enriching experience.
Type 2 Diabetes is a progressive disease that occurs as a result of metabolic dysfunction. Gastrointestinal hormones produced as a result of nutrient ingestion contribute to the secretion of insulin. They not only enhance the secretion of insulin, but also play a vital role in the neogenesis and proliferation of Pancreatic beta cells and the inhibition of glucagons. This presentation is a visual account of Type 2 Diabetes and the beneficial use of DPP-IV inhibitors in taking control of the body's natural metabolism.
Type 2 Diabetes is a progressive disease that occurs as a result of metabolic dysfunction. Gastrointestinal hormones produced as a result of nutrient ingestion contribute to the secretion of insulin. They not only enhance the secretion of insulin, but also play a vital role in the neogenesis and proliferation of Pancreatic beta cells and the inhibition of glucagons. This presentation is a visual account of Type 2 Diabetes and the beneficial use of DPP-IV inhibitors in taking control of the body's natural metabolism.
Anthony H. Barnett, MD, FRCP, is a Professor of Medicine at the University of Birmingham, running one of the biggest Diabetes Units in the United Kingdom. He is the Consultant Physician and Clinical Director of Diabetes and Endocrinology at Birmingham Heartlands Hospital. His research activities focus on genetics of diabetes and other "complex" diseases, causes leading to complications during diabetes as well as development of new therapies to treat diabetes and associated vascular complications. Prof. Barnett is the editor of journals like Modern Diabetes Management, Modern Hypertension Management and Obesity in Practice, in addition to publishing more than 300 original scientific papers.
| Erscheint lt. Verlag | 30.1.2008 |
|---|---|
| Zusatzinfo | Illustrations, unspecified |
| Sprache | englisch |
| Themenwelt | Sachbuch/Ratgeber ► Gesundheit / Leben / Psychologie ► Krankheiten / Heilverfahren |
| Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie | |
| Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie | |
| ISBN-10 | 981-4206-17-2 / 9814206172 |
| ISBN-13 | 978-981-4206-17-4 / 9789814206174 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
